Results 161 to 170 of about 9,597 (197)
Some of the next articles are maybe not open access.

Mucocutaneous leishmaniasis (espundia)

Postgraduate Medical Journal, 2020
An 89-year-old Spanish man presented with a 15-month history of a slowly growing inflammatory lesion in his left nasolabial region (figure 1A). The process was slightly painful and pruritic. The patient was otherwise asymptomatic. A CT/positron emission tomography showed hypermetabolism in the affected …
Bernardino Roca, Manuel Roca
openaire   +2 more sources

Imported mucocutaneous leishmaniasis

Clinical and Experimental Dermatology, 1996
We report a case of mucocutaneous leishmaniasis in a otherwise fit Caucasian man who had traveled in an endemic area. Initial tissue microscopy failed to identify the causative organism, which was only determined by subsequent culture as Leishmania braziliensis.
J L, Rosbotham   +4 more
openaire   +2 more sources

American Mucocutaneous Leishmaniasis

Southern Medical Journal, 1977
Presented is a well-documented, autochthonous case of mucocutaneous leishmaniasis, a protozoan disease endemic to Asia, Africa, Southern Europe, South America, and Central America, which until recently was not found in North America. Diagnosis is made by positive culture on NNN media, positive serodiagnosis, positive Montenegro skin test, the presence ...
D, Barlow   +3 more
openaire   +2 more sources

Cutaneous and Mucocutaneous Leishmaniasis

Infectious Disease Clinics of North America, 2012
Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated,
Hiro, Goto   +1 more
openaire   +2 more sources

Mucocutaneous Leishmaniasis and HIV

Dermatology, 1994
Mucocutaneous leishmaniasis is a rare disease in Europe. Relapses after treatment are more frequent than in visceral leishmaniasis. HIV patients infected by Leishmania have frequently visceral involvement, and responses to treatment are poor. Mucocutaneous leishmaniasis in HIV-infected patients has rarely been reported.
E S, Miralles   +5 more
openaire   +2 more sources

American Mucocutaneous Leishmaniasis

Dermatologic Clinics, 1994
American mucocutaneous leishmaniasis is produced by several species of Leishmania. The microorganism lives in jungle reservoirs and is transmitted by sandflies. After infection, a complex set of immunologic phenomena takes place. Most lesions tend to heal, but some clinical forms are relentlessly progressive and resistant to available therapy ...
openaire   +2 more sources

Mucocutaneous leishmaniasis presenting as facial cellulitis

The Journal of Laryngology & Otology, 2005
We report a case of mucocutaneous leishmaniasis caused by Leishmania viannia braziliensis. Despite several courses of both oral and intravenous antibiotics no improvement was seen. This case highlights the importance of taking a thorough history, including details of recent travel, and considering rarer causes when no improvement with antibiotics is ...
Rima, Clayton, Sophie, Grabczynska
openaire   +2 more sources

Mucocutaneous Leishmaniasis Masquerading as Wegener Granulomatosis

JCR: Journal of Clinical Rheumatology, 2010
A 43-year-old Brazilian female presented in 2001 with nasal stuffiness and sinusitis. A biopsy was consistent with limited Wegener's granulomatosis although antineutrophil cytoplasmic antibodies were negative. Her nasal inflammation progressed despite trials of prednisone, methotrexate, and azathioprine.
Ernest, Brahn   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy